Two  ||| S:0 E:4 ||| CD
novel  ||| S:4 E:10 ||| NN
CBTs  ||| S:10 E:15 ||| NN
for  ||| S:15 E:19 ||| IN
adolescents  ||| S:19 E:31 ||| NNS
with  ||| S:31 E:36 ||| IN
ADHD ||| S:36 E:40 ||| NNP
:  ||| S:40 E:42 ||| :
the  ||| S:42 E:46 ||| DT
value  ||| S:46 E:52 ||| NN
of  ||| S:52 E:55 ||| IN
planning  ||| S:55 E:64 ||| VBG
skills  ||| S:64 E:71 ||| NNS
Adolescents  ||| S:71 E:83 ||| NNP
with  ||| S:83 E:88 ||| IN
ADHD  ||| S:88 E:93 ||| NNP
have  ||| S:93 E:98 ||| VBP
planning  ||| S:98 E:107 ||| VBG
problems ||| S:107 E:115 ||| NNS
,  ||| S:115 E:117 ||| ,
often  ||| S:117 E:123 ||| RB
affecting  ||| S:123 E:133 ||| VBG
school-  ||| S:133 E:141 ||| JJ
and  ||| S:141 E:145 ||| CC
social  ||| S:145 E:152 ||| JJ
functioning ||| S:152 E:163 ||| NN
.  ||| S:163 E:165 ||| .
Evidence-based  ||| S:165 E:180 ||| JJ
treatments  ||| S:180 E:191 ||| NNS
for  ||| S:191 E:195 ||| IN
adolescents  ||| S:195 E:207 ||| NNS
with  ||| S:207 E:212 ||| IN
ADHD  ||| S:212 E:217 ||| NNP
are  ||| S:217 E:221 ||| VBP
scarce  ||| S:221 E:228 ||| JJ
and  ||| S:228 E:232 ||| CC
treatment  ||| S:232 E:242 ||| NN
drop-out  ||| S:242 E:251 ||| JJ
rates  ||| S:251 E:257 ||| NNS
are  ||| S:257 E:261 ||| VBP
substantial ||| S:261 E:272 ||| JJ
.  ||| S:272 E:274 ||| .
The  ||| S:274 E:278 ||| DT
effectiveness  ||| S:278 E:292 ||| NN
of  ||| S:292 E:295 ||| IN
two  ||| S:295 E:299 ||| CD
new ||| S:299 E:302 ||| JJ
,  ||| S:302 E:304 ||| ,
individual ||| S:304 E:314 ||| JJ
,  ||| S:314 E:316 ||| ,
short-term  ||| S:316 E:327 ||| JJ
cognitive  ||| S:327 E:337 ||| JJ
behavioral  ||| S:337 E:348 ||| JJ
therapies  ||| S:348 E:358 ||| NNS
( ||| S:358 E:359 ||| -LRB-
CBT ||| S:359 E:362 ||| NNP
)  ||| S:362 E:364 ||| -RRB-
was  ||| S:364 E:368 ||| VBD
investigated ||| S:368 E:380 ||| VBN
:  ||| S:380 E:382 ||| :
One  ||| S:382 E:386 ||| CD
with  ||| S:386 E:391 ||| IN
an  ||| S:391 E:394 ||| DT
aim  ||| S:394 E:398 ||| NN
on  ||| S:398 E:401 ||| IN
improving  ||| S:401 E:411 ||| VBG
planning  ||| S:411 E:420 ||| NN
skills  ||| S:420 E:427 ||| NNS
and  ||| S:427 E:431 ||| CC
one  ||| S:431 E:435 ||| CD
solution-focused  ||| S:435 E:452 ||| JJ
treatment  ||| S:452 E:462 ||| NN
( ||| S:462 E:463 ||| -LRB-
SFT ||| S:463 E:466 ||| NNP
)  ||| S:466 E:468 ||| -RRB-
without  ||| S:468 E:476 ||| IN
such  ||| S:476 E:481 ||| PDT
an  ||| S:481 E:484 ||| DT
aim ||| S:484 E:487 ||| NN
.  ||| S:487 E:489 ||| .
Motivational  ||| S:489 E:502 ||| NNP
Interviewing  ||| S:502 E:515 ||| NNP
elements  ||| S:515 E:524 ||| NNS
were  ||| S:524 E:529 ||| VBD
added  ||| S:529 E:535 ||| VBN
to  ||| S:535 E:538 ||| TO
both  ||| S:538 E:543 ||| DT
treatments  ||| S:543 E:554 ||| NNS
to  ||| S:554 E:557 ||| TO
enhance  ||| S:557 E:565 ||| VB
treatment  ||| S:565 E:575 ||| NN
compliance ||| S:575 E:585 ||| NN
.  ||| S:585 E:587 ||| .
In  ||| S:587 E:590 ||| IN
a  ||| S:590 E:592 ||| DT
multi-center  ||| S:592 E:605 ||| JJ
randomized  ||| S:605 E:616 ||| JJ
clinical  ||| S:616 E:625 ||| JJ
trial ||| S:625 E:630 ||| NN
,  ||| S:630 E:632 ||| ,
159  ||| S:632 E:636 ||| CD
adolescents  ||| S:636 E:648 ||| NNS
( ||| S:648 E:649 ||| -LRB-
12-17  ||| S:649 E:655 ||| CD
years ||| S:655 E:660 ||| NNS
)  ||| S:660 E:662 ||| -RRB-
with  ||| S:662 E:667 ||| IN
ADHD  ||| S:667 E:672 ||| NNP
were  ||| S:672 E:677 ||| VBD
randomly  ||| S:677 E:686 ||| RB
assigned  ||| S:686 E:695 ||| VBN
to  ||| S:695 E:698 ||| TO
one  ||| S:698 E:702 ||| CD
of  ||| S:702 E:705 ||| IN
both  ||| S:705 E:710 ||| DT
treatments ||| S:710 E:720 ||| NNS
.  ||| S:720 E:722 ||| .
Pre- ||| S:722 E:726 ||| NNP
,  ||| S:726 E:728 ||| ,
post-  ||| S:728 E:734 ||| JJ
and  ||| S:734 E:738 ||| CC
3-month  ||| S:738 E:746 ||| CD
follow-up  ||| S:746 E:756 ||| JJ
data  ||| S:756 E:761 ||| NNS
were  ||| S:761 E:766 ||| VBD
gathered  ||| S:766 E:775 ||| VBN
on  ||| S:775 E:778 ||| IN
five  ||| S:778 E:783 ||| CD
domains ||| S:783 E:790 ||| NNS
:  ||| S:790 E:792 ||| :
Parent-rated  ||| S:792 E:805 ||| NNP
ADHD ||| S:805 E:809 ||| NNP
,  ||| S:809 E:811 ||| ,
planning  ||| S:811 E:820 ||| VBG
problems  ||| S:820 E:829 ||| NNS
and  ||| S:829 E:833 ||| CC
executive  ||| S:833 E:843 ||| JJ
functioning  ||| S:843 E:855 ||| NNS
( ||| S:855 E:856 ||| -LRB-
primary  ||| S:856 E:864 ||| JJ
outcomes ||| S:864 E:872 ||| NNS
) ||| S:872 E:873 ||| -RRB-
,  ||| S:873 E:875 ||| ,
neuropsychological  ||| S:875 E:894 ||| JJ
measures  ||| S:894 E:903 ||| NNS
of  ||| S:903 E:906 ||| IN
planning ||| S:906 E:914 ||| NN
,  ||| S:914 E:916 ||| ,
comorbid  ||| S:916 E:925 ||| JJ
symptoms ||| S:925 E:933 ||| NNS
,  ||| S:933 E:935 ||| ,
general  ||| S:935 E:943 ||| JJ
functioning ||| S:943 E:954 ||| NN
,  ||| S:954 E:956 ||| ,
and  ||| S:956 E:960 ||| CC
teacher  ||| S:960 E:968 ||| NN
measures ||| S:968 E:976 ||| NNS
.  ||| S:976 E:978 ||| .
Attrition  ||| S:978 E:988 ||| NNP
was  ||| S:988 E:992 ||| VBD
low  ||| S:992 E:996 ||| JJ
in  ||| S:996 E:999 ||| IN
both  ||| S:999 E:1004 ||| DT
treatments  ||| S:1004 E:1015 ||| NNS
( ||| S:1015 E:1016 ||| -LRB-
5 ||| S:1016 E:1017 ||| CD
% ||| S:1017 E:1018 ||| NN
) ||| S:1018 E:1019 ||| -RRB-
.  ||| S:1019 E:1021 ||| .
Adolescents  ||| S:1021 E:1033 ||| NNP
improved  ||| S:1033 E:1042 ||| VBD
significantly  ||| S:1042 E:1056 ||| RB
between  ||| S:1056 E:1064 ||| IN
pre-  ||| S:1064 E:1069 ||| JJ
and  ||| S:1069 E:1073 ||| CC
post-test  ||| S:1073 E:1083 ||| JJ
with  ||| S:1083 E:1088 ||| IN
large  ||| S:1088 E:1094 ||| JJ
effect  ||| S:1094 E:1101 ||| NN
sizes  ||| S:1101 E:1107 ||| NNS
on  ||| S:1107 E:1110 ||| IN
all  ||| S:1110 E:1114 ||| DT
domains ||| S:1114 E:1121 ||| NN
.  ||| S:1121 E:1123 ||| .
Improvements  ||| S:1123 E:1136 ||| NNS
remained  ||| S:1136 E:1145 ||| VBD
stable  ||| S:1145 E:1152 ||| JJ
or  ||| S:1152 E:1155 ||| CC
continued  ||| S:1155 E:1165 ||| VBD
to  ||| S:1165 E:1168 ||| TO
improve  ||| S:1168 E:1176 ||| VB
from  ||| S:1176 E:1181 ||| IN
post-test  ||| S:1181 E:1191 ||| JJ
to  ||| S:1191 E:1194 ||| TO
follow-up ||| S:1194 E:1203 ||| JJ
,  ||| S:1203 E:1205 ||| ,
also  ||| S:1205 E:1210 ||| RB
when  ||| S:1210 E:1215 ||| WRB
controlling  ||| S:1215 E:1227 ||| VBG
for  ||| S:1227 E:1231 ||| IN
medication  ||| S:1231 E:1242 ||| NN
use ||| S:1242 E:1245 ||| NN
.  ||| S:1245 E:1247 ||| .
Marginally  ||| S:1247 E:1258 ||| RB
significant  ||| S:1258 E:1270 ||| JJ
differences  ||| S:1270 E:1282 ||| NNS
were  ||| S:1282 E:1287 ||| VBD
found  ||| S:1287 E:1293 ||| VBN
in  ||| S:1293 E:1296 ||| IN
favor  ||| S:1296 E:1302 ||| NN
of  ||| S:1302 E:1305 ||| IN
the  ||| S:1305 E:1309 ||| DT
planning-focused  ||| S:1309 E:1326 ||| JJ
treatment ||| S:1326 E:1335 ||| NN
:  ||| S:1335 E:1337 ||| :
parents  ||| S:1337 E:1345 ||| NNS
and  ||| S:1345 E:1349 ||| CC
therapists  ||| S:1349 E:1360 ||| NNS
evaluated  ||| S:1360 E:1370 ||| VBD
this  ||| S:1370 E:1375 ||| DT
treatment  ||| S:1375 E:1385 ||| NN
more  ||| S:1385 E:1390 ||| RBR
positively  ||| S:1390 E:1401 ||| RB
than  ||| S:1401 E:1406 ||| IN
SFT  ||| S:1406 E:1410 ||| NNP
and  ||| S:1410 E:1414 ||| CC
the  ||| S:1414 E:1418 ||| DT
planning-focused  ||| S:1418 E:1435 ||| JJ
treatment  ||| S:1435 E:1445 ||| NN
showed  ||| S:1445 E:1452 ||| VBD
more  ||| S:1452 E:1457 ||| JJR
reduction  ||| S:1457 E:1467 ||| NN
of  ||| S:1467 E:1470 ||| IN
parent-rated  ||| S:1470 E:1483 ||| JJ
planning  ||| S:1483 E:1492 ||| NN
problems ||| S:1492 E:1500 ||| NNS
.  ||| S:1500 E:1502 ||| .
Two  ||| S:1502 E:1506 ||| CD
new  ||| S:1506 E:1510 ||| JJ
CBTs  ||| S:1510 E:1515 ||| NN
with  ||| S:1515 E:1520 ||| IN
integrated  ||| S:1520 E:1531 ||| JJ
motivational  ||| S:1531 E:1544 ||| JJ
components  ||| S:1544 E:1555 ||| NNS
were  ||| S:1555 E:1560 ||| VBD
feasible  ||| S:1560 E:1569 ||| JJ
and  ||| S:1569 E:1573 ||| CC
attrition  ||| S:1573 E:1583 ||| NN
was  ||| S:1583 E:1587 ||| VBD
low ||| S:1587 E:1590 ||| JJ
.  ||| S:1590 E:1592 ||| .
ADHD  ||| S:1592 E:1597 ||| NNP
symptoms  ||| S:1597 E:1606 ||| NNS
and  ||| S:1606 E:1610 ||| CC
co-existing  ||| S:1610 E:1622 ||| JJ
problems  ||| S:1622 E:1631 ||| NNS
of  ||| S:1631 E:1634 ||| IN
the  ||| S:1634 E:1638 ||| DT
adolescents  ||| S:1638 E:1650 ||| NN
improved  ||| S:1650 E:1659 ||| VBN
from  ||| S:1659 E:1664 ||| IN
pre-test  ||| S:1664 E:1673 ||| JJ
to  ||| S:1673 E:1676 ||| TO
3  ||| S:1676 E:1678 ||| CD
months  ||| S:1678 E:1685 ||| NNS
after  ||| S:1685 E:1691 ||| IN
treatment ||| S:1691 E:1700 ||| NN
.  ||| S:1700 E:1702 ||| .
As  ||| S:1702 E:1705 ||| IN
the  ||| S:1705 E:1709 ||| DT
planning-focused  ||| S:1709 E:1726 ||| JJ
treatment  ||| S:1726 E:1736 ||| NN
was  ||| S:1736 E:1740 ||| VBD
evaluated  ||| S:1740 E:1750 ||| VBN
more  ||| S:1750 E:1755 ||| RBR
positive  ||| S:1755 E:1764 ||| JJ
and  ||| S:1764 E:1768 ||| CC
had  ||| S:1768 E:1772 ||| VBD
marginal  ||| S:1772 E:1781 ||| JJ
additional  ||| S:1781 E:1792 ||| JJ
beneficial  ||| S:1792 E:1803 ||| JJ
effects  ||| S:1803 E:1811 ||| NNS
to  ||| S:1811 E:1814 ||| TO
SFT ||| S:1814 E:1817 ||| NNP
,  ||| S:1817 E:1819 ||| ,
especially  ||| S:1819 E:1830 ||| RB
planning-focused  ||| S:1830 E:1847 ||| JJ
CBT  ||| S:1847 E:1851 ||| NNP
seems  ||| S:1851 E:1857 ||| VBZ
promising  ||| S:1857 E:1867 ||| VBG
to  ||| S:1867 E:1870 ||| TO
fill  ||| S:1870 E:1875 ||| VB
the  ||| S:1875 E:1879 ||| DT
gap  ||| S:1879 E:1883 ||| NN
in  ||| S:1883 E:1886 ||| IN
available  ||| S:1886 E:1896 ||| JJ
treatments  ||| S:1896 E:1907 ||| NNS
for  ||| S:1907 E:1911 ||| IN
adolescents  ||| S:1911 E:1923 ||| NNS
with  ||| S:1923 E:1928 ||| IN
ADHD ||| S:1928 E:1932 ||| NNP
.  ||| S:1932 E:1934 ||| .
